CSMYF (COSMOS Pharmaceutical) EV-to-FCF: (As of Jul. 13, 2026)

COSMOS Pharmaceutical  (OTCPK:CSMYF) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

COSMOS Pharmaceutical's PE Ratio (TTM) for today is calculated as:

COSMOS Pharmaceutical's share price for today is $37.06.
COSMOS Pharmaceutical's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Feb. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $2.627.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.

COSMOS Pharmaceutical EV-to-FCF Related Terms

The historical data trend for COSMOS Pharmaceutical's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

COSMOS Pharmaceutical EV-to-FCF Chart

COSMOS Pharmaceutical Annual Data
	Trend	May17	May18	May19	May20	May21	May22	May23	May24	May25	May26
EV-to-FCF		Get a 7-Day Free Trial					-40.27	63.78	-763.23	-806.66	-41.27

COSMOS Pharmaceutical Quarterly Data
	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24	May24	Aug24	Nov24	Feb25	May25	Aug25	Nov25	Feb26	May26
EV-to-FCF	Get a 7-Day Free Trial															-806.66	0.00	0.00	0.00	0.00

COSMOS Pharmaceutical EV-to-FCF Competitor Comparison

For the Pharmaceutical Retailers subindustry, COSMOS Pharmaceutical's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

COSMOS Pharmaceutical EV-to-FCF vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, COSMOS Pharmaceutical's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where COSMOS Pharmaceutical's EV-to-FCF falls into.

COSMOS Pharmaceutical EV-to-FCF Calculation

COSMOS Pharmaceutical's EV-to-FCF for today is calculated as:

COSMOS Pharmaceutical's current Enterprise Value is $3,240 Mil.
COSMOS Pharmaceutical's Free Cash Flow for the trailing twelve months (TTM) ended in Feb. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

COSMOS Pharmaceutical Business Description